These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35533688)

  • 1. [Fecal Microbiota Transfer (FMT) in Children and Adolescents - Review and statement by the GPGE microbiome working group].
    Joachim A; Schwerd T; Hölz H; Sokollik C; Konrad LA; Jordan A; Lanzersdorfer R; Schmidt-Choudhury A; Hünseler C; Adam R
    Z Gastroenterol; 2022 Jun; 60(6):963-969. PubMed ID: 35533688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolving Landscape of Fecal Microbial Transplantation.
    Shao T; Hsu R; Hacein-Bey C; Zhang W; Gao L; Kurth MJ; Zhao H; Shuai Z; Leung PSC
    Clin Rev Allergy Immunol; 2023 Oct; 65(2):101-120. PubMed ID: 36757537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation.
    Vindigni SM; Surawicz CM
    Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.
    Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G
    Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    Nicholson MR; Alexander E; Ballal S; Davidovics Z; Docktor M; Dole M; Gisser JM; Goyal A; Hourigan SK; Jensen MK; Kaplan JL; Kellermayer R; Kelsen JR; Kennedy MA; Khanna S; Knackstedt ED; Lentine J; Lewis JD; Michail S; Mitchell PD; Oliva-Hemker M; Patton T; Queliza K; Sidhu S; Solomon AB; Suskind DL; Weatherly M; Werlin S; de Zoeten EF; Kahn SA;
    J Crohns Colitis; 2022 Jun; 16(5):768-777. PubMed ID: 34788420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research trends on clinical fecal microbiota transplantation: A biliometric analysis from 2001 to 2021.
    Li Y; Ouyang Y; He C
    Front Immunol; 2022; 13():991788. PubMed ID: 36353639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
    Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
    J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
    Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
    Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.
    Nicholson MR; Mitchell PD; Alexander E; Ballal S; Bartlett M; Becker P; Davidovics Z; Docktor M; Dole M; Felix G; Gisser J; Hourigan SK; Jensen MK; Kaplan JL; Kelsen J; Kennedy M; Khanna S; Knackstedt E; Leier M; Lewis J; Lodarek A; Michail S; Oliva-Hemker M; Patton T; Queliza K; Russell GH; Singh N; Solomon A; Suskind DL; Werlin S; Kellermayer R; Kahn SA
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):612-619.e1. PubMed ID: 31009795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fecal microbiota transplantation].
    Lübbert C; Salzberger B; Mössner J
    Internist (Berl); 2017 May; 58(5):456-468. PubMed ID: 28235986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
    Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.
    Brumbaugh DE; De Zoeten EF; Pyo-Twist A; Fidanza S; Hughes S; Dolan SA; Child J; Dominguez SR
    J Pediatr; 2018 Mar; 194():123-127.e1. PubMed ID: 29198534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases.
    Ghani R; Mullish BH; Roberts LA; Davies FJ; Marchesi JR
    Gut Microbes; 2022; 14(1):2038856. PubMed ID: 35230889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.